Skip to main content
SpringerLink
Log in

Drug pricing decisions are now more critical than ever due to the expanding generics market, expiring patents and reduced new drug discoveries.

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Kalorama Information.Generic Onslaught Makes Drug Pricing Decisions More Critical Than Ever. Media Release: 3 Jan 2008. Available from: URL: http://www.kaloramainformation.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drug pricing decisions are now more critical than ever due to the expanding generics market, expiring patents and reduced new drug discoveries.. Pharmacoecon. Outcomes News 544, 11 (2008). https://doi.org/10.2165/00151234-200805440-00029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805440-00029

Keywords

Search

Navigation